Heartburn Relief: AstraZeneca Wins Nexium Antitrust Trial
An 11-person jury decided in favor of defendants AstraZeneca PLC and Ranbaxy Laboratories, Inc. in the first pay-for-delay class action trial since the United States Supreme Court in FTC v. Actavis, Inc. opened the door on antitrust suits based on patent settlements. Teva Pharmaceutical Industries, Ltd. was also defending the suit before reaching a settlement shortly before the trial ended.
Novartis-Cipla battle shakes up Indian pharma industry
The Indian pharmaceutical industry has been rocked by yet another high-profile patent battle between a local drug maker and a global giant. Swiss drug manufacturer Novartis has sued Cipla for infringing on its patent for respiratory drug Onbrez.
Verizon Announces That They Have Entered Into A Patent Licensing Agreement With Google
Patent battle does nothing to help innovation, all it does it waste time and resources that could be used for doing better things to actually innovate. Google seems to firmly believe this, and apparently so does Verizon Wireless, as they have both just announced that they will be entering into a patent licensing agreement to share ideas and promote innovation.
EFF To Challenge Patent Troll at Public Hearing
The EFF has gathered evidence of what’s called “prior art.” In this case these are examples of serialized audio programs being distributed online before Personal Audio was granted its patent. EFF turned up online audio distributed to the public by CNN and the CBC as early as 1993 that in April the Patent Office ruled is admissible.
